




Searching News Database: Medarex
HSMN NewsFeed - 27 Mar 2012
Synta Announces Appointment of George Farmer, Ph.D., as Vice President, Corporate Development
Synta Announces Appointment of George Farmer, Ph.D., as Vice President, Corporate Development
HSMN NewsFeed - 18 Aug 2009
Kolltan Pharmaceuticals Expands Board of Directors and Senior Executive Team
Kolltan Pharmaceuticals Expands Board of Directors and Senior Executive Team
HSMN NewsFeed - 17 Mar 2008
Avalon Pharmaceuticals Appoints Philip Frost, M.D., Ph.D., to Its Board of Directors
Avalon Pharmaceuticals Appoints Philip Frost, M.D., Ph.D., to Its Board of Directors
HSMN NewsFeed - 22 Oct 2007
AVANT Immunotherapeutics, Inc. and Celldex Therapeutics, Inc. Announce Merger Agreement
AVANT Immunotherapeutics, Inc. and Celldex Therapeutics, Inc. Announce Merger Agreement
HSMN NewsFeed - 5 Sep 2007
Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
HSMN NewsFeed - 6 Aug 2007
Avalon Pharmaceuticals Appoints Bradley G. Lorimier Chairman of Board of Directors
Avalon Pharmaceuticals Appoints Bradley G. Lorimier Chairman of Board of Directors
HSMN NewsFeed - 18 Jul 2007
Medarex Announces Initiation by Licensing Partner of Phase III Clinical Trial for Muckle Wells Syndrome
Medarex Announces Initiation by Licensing Partner of Phase III Clinical Trial for Muckle Wells Syndrome
HSMN NewsFeed - 3 May 2007
Avalon Pharmaceuticals, Inc. Names C. Eric Winzer New Chief Financial Officer
Avalon Pharmaceuticals, Inc. Names C. Eric Winzer New Chief Financial Officer
HSMN NewsFeed - 26 Dec 2006
IDM Pharma Announces Acceptance for Review of the NDA for Junovan(TM) (Mifamurtide)
IDM Pharma Announces Acceptance for Review of the NDA for Junovan(TM) (Mifamurtide)
HSMN NewsFeed - 14 Sep 2006
Genmab Initiates HuMax-EGFr Pivotal Study In Refractory Head and Neck Cancer
Genmab Initiates HuMax-EGFr Pivotal Study In Refractory Head and Neck Cancer
HSMN NewsFeed - 15 Aug 2006
IDM Pharma Appoints Sylvie Gregoire, Pharm. D., as Executive Chair of the Board of Directors
IDM Pharma Appoints Sylvie Gregoire, Pharm. D., as Executive Chair of the Board of Directors
HSMN NewsFeed - 28 Jul 2006
Steven Fischkoff, M.D. Joins Palatin Technologies as Vice President of Clinical Development
Steven Fischkoff, M.D. Joins Palatin Technologies as Vice President of Clinical Development
HSMN NewsFeed - 14 Mar 2006
IDM and Medison Pharma Sign an Exclusive Marketing Agreement for Junovan(TM) in Israel
IDM and Medison Pharma Sign an Exclusive Marketing Agreement for Junovan(TM) in Israel
HSMN NewsFeed - 6 Mar 2006
PharmAthene and Medarex Receive Orphan Drug Designation for Valortim(TM) to Treat Anthrax Infection
PharmAthene and Medarex Receive Orphan Drug Designation for Valortim(TM) to Treat Anthrax Infection
HSMN NewsFeed - 21 Feb 2006
IDM and GENESIS Pharma Sign an Exclusive Marketing Agreement for Junovan(TM) in South East Europe
IDM and GENESIS Pharma Sign an Exclusive Marketing Agreement for Junovan(TM) in South East Europe
Additional items found! 79

Members Archive contains
79 additional stories matching:
Medarex
(Password required)
Medarex
(Password required)